Articles from XOMA Royalty Corporation; LAVA Therapeutics N.V.

XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right

XOMA Royalty adds milestone and royalty economics associated with two partnered assets

By XOMA Royalty Corporation; LAVA Therapeutics N.V. · Via GlobeNewswire · August 4, 2025